Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional)
ID: 357031Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Research Infrastructure Development for Interdisciplinary Aging Studies" (R61/R33 - Clinical Trial Optional) aimed at advancing interdisciplinary research in aging. This initiative encourages applicants to develop novel research infrastructure that addresses critical questions in aging through collaborative efforts across various disciplines, including biological aging and behavioral science. The funding is structured in two phases, providing up to $500,000 annually for initial activities over two years (R61) followed by three years for expanded activities (R33), with applications accepted from eligible institutions and organizations until December 3, 2025. For further details, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-25-218.html.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Health and Human Services is issuing a funding opportunity aimed at developing research infrastructure to advance interdisciplinary aging studies under the National Institutes of Health (NIH). This funding initiative, titled "Research Infrastructure Development for Interdisciplinary Aging Studies" (R61/R33 - Clinical Trial Optional), encourages interdisciplinary collaborations to address critical questions about aging. The funding is phased, providing support for initial activities for up to two years (R61) followed by three years for expanded activities (R33). Eligible applicants include various educational institutions and organizations, with a budget limit of $500,000 annually during both phases. The application process emphasizes adherence to specific guidelines and milestones, ensuring that proposed projects benefit the broader research community. Key research focuses span multiple disciplines, including biological aging, behavioral science, and clinical gerontology. This initiative aims to enhance understanding of aging processes, address health disparities, and promote innovative solutions in aging research. The proposal submission begins on June 2, 2025, with an expiration date for applications set for December 3, 2025, ensuring that responsive and meritorious projects are funded to further the science of aging.
    Similar Opportunities
    Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Multidisciplinary Studies of HIV/AIDS and Aging," aimed at exploring the intersection of HIV and aging. This initiative seeks to enhance understanding of the biological, clinical, and socio-behavioral aspects of aging in the context of HIV infection, while also improving strategies for testing, prevention, and treatment of HIV-related health complications. Given the increasing number of older adults living with HIV, this research is crucial for addressing public health challenges and improving healthcare delivery across diverse populations. The funding supports exploratory research under the R21 mechanism, with a maximum budget of $275,000 for two years, and applications are due between May 2025 and January 2027. For more information, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-25-355.html.
    Transition to Aging Research for Predoctoral Students
    National Institutes of Health
    The National Institutes of Health (NIH) is set to announce a funding opportunity titled "Transition to Aging Research for Predoctoral Students," aimed at supporting late-stage graduate students pursuing aging-related research. This initiative will provide a two-phase award to facilitate the completion of doctoral dissertation projects and offer training supports to help graduates transition into competitive postdoctoral positions in aging research. The program is designed to recruit and retain emerging investigators in the field of aging, with applications expected to open on November 1, 2025, and close on February 17, 2026. For further inquiries, interested parties can contact Jamie Lahvic, Ph.D., at NIATraining@mail.nih.gov or by phone at 240-930-0700.
    Aging Research Dissertation Awards to Promote Diversity (R36 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH), specifically through the National Institute on Aging (NIA), is offering Aging Research Dissertation Awards (R36) aimed at promoting diversity within the scientific research workforce focused on aging and health-related issues. This funding opportunity is designed for senior graduate students from underrepresented backgrounds in biomedical and behavioral sciences, supporting their dissertation research in various aging-related fields. NIH allocates approximately $768,420 annually for up to 10 awards from FY 2025 to 2027, with each award covering up to $42,500 in salary and $28,656 for additional expenses, excluding tuition. Interested applicants should note that the application process begins on January 16, 2025, with a final submission deadline of November 17, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-24-130.html.
    Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional) grant, aimed at supporting large-scale, multidisciplinary research projects focused on aging. This opportunity encourages the formation of collaborative teams that will propose integrated research programs addressing a common hypothesis related to aging, with an emphasis on coordination among various project components. While applications are not currently being solicited, potential applicants are encouraged to prepare meaningful collaborations and responsive projects in anticipation of the upcoming Notice of Funding Opportunity (NOFO), with an estimated synopsis posting date of March 25, 2026, and a closing date of May 25, 2026. For further inquiries, interested parties can contact the NIA Scientific Contact at niascicontact@mail.nih.gov.
    Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) titled "Multidisciplinary Studies of HIV/AIDS and Aging," inviting applications for research that explores the intersection of HIV and aging. The primary objectives of this grant are to enhance understanding of the biological, clinical, and socio-behavioral aspects of aging in individuals living with HIV, as well as to improve strategies for testing, preventing, and treating HIV and managing related health complications. This funding opportunity is significant for advancing health interventions for older adults affected by HIV, with eligible applicants including a wide range of institutions such as higher education entities, community organizations, and tribal governments. Interested parties should note that the application deadline is May 7, 2027, and can find further details and guidance by contacting NIH Grants Information at grantsinfo@nih.gov or visiting the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-24-091.html.
    Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)" aimed at enhancing research on the intersection of HIV and aging. The program seeks applications that focus on improving the understanding of biological, clinical, and socio-behavioral aspects of aging in the context of HIV infection, as well as developing better methods for testing, preventing, and managing HIV-related health issues among older populations. This initiative is particularly significant given the projected increase in the prevalence of HIV among older adults, which is expected to rise from 53% to over 70% by 2030, highlighting the urgent need to address the complex challenges associated with aging and HIV. Interested applicants can submit proposals until January 7, 2027, with no budget limits as long as they align with project needs; for further inquiries, contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-25-354.html.
    Advancing Healthcare for Older Adults from Populations that Experience Health Disparities (R01 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Healthcare for Older Adults from Populations that Experience Health Disparities" under the R01 Clinical Trial Optional grant program. This initiative aims to enhance the science and implementation of healthcare research focused on older adults from populations facing health disparities, specifically targeting improvements in screening, diagnostic, and clinical care guidelines, as well as fostering shared decision-making between clinicians and patients. The research is particularly significant for addressing the unique health challenges encountered by older adults from racial and ethnic minorities and underserved communities, emphasizing innovative care solutions that consider social determinants of health. Interested applicants can find more information and apply through the NIH Grants website, with the application opening on January 5, 2025, and a close date set for January 7, 2028. For inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov.
    NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Aging (NIA), has announced the NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required) to support investigator-initiated multi-site interventional clinical trials focused on aging-related research. This funding opportunity aims to foster innovative biomedical and behavioral studies that address the complexities of aging, particularly in populations with multiple chronic conditions and polypharmacy. Eligible applicants include a diverse range of organizations such as higher education institutions, nonprofits, and tribal governments, with an emphasis on rigorous trial designs that ensure ethical considerations and participant diversity. Interested parties should note that the application deadline is January 7, 2026, and further details can be found at the provided NIH grants link, with inquiries directed to grantsinfo@nih.gov.
    Aging Research Dissertation Awards to Promote Diversity (R36 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Aging Research Dissertation Awards to Promote Diversity (R36), aimed at supporting graduate students from diverse backgrounds engaged in aging-related health research. This funding opportunity encourages applications from underrepresented groups in the biomedical and behavioral sciences, with the goal of enriching the research workforce and addressing complex health challenges in an aging population. The NIH anticipates awarding approximately 10 grants annually, with a total investment of around $768,420 between FY 2025 and 2027, providing up to $42,500 for individual salaries and up to $28,656 for additional research-related expenses. Interested applicants must submit their proposals by January 16, 2024, with awards expected to commence in July 2024. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Notice of Intent to Publish a Funding Opportunity Announcement for Facilitating Preclinical and Early Phase Human Studies for New Therapeutics (UG3/UH3 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a Notice of Funding Opportunity (NOFO) for facilitating preclinical and early phase human studies for new therapeutics, specifically targeting aging-related conditions. This initiative aims to advance T1 translational aging research, focusing on therapeutics that progress from preclinical stages to first-in-human trials, addressing conditions such as sarcopenia and heart failure with preserved ejection fraction (HFpEF). The funding opportunity, categorized under health-related activities, will utilize the UG3/UH3 Cooperative Agreement mechanism, with an estimated total program funding of $2.5 million. Interested applicants should prepare to submit their applications by fall 2024, with the NOFO expected to be published in summer 2024 and awards anticipated by July 2025.